StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
26
This month
1
This year
2
Publishing Date
2024 - 04 - 09
1
2024 - 02 - 04
1
2023 - 10 - 11
1
2023 - 09 - 26
1
2022 - 10 - 13
1
2022 - 06 - 17
1
2022 - 05 - 31
1
2022 - 03 - 21
1
2022 - 03 - 09
1
2022 - 02 - 16
1
2021 - 12 - 28
1
2021 - 09 - 28
1
2021 - 09 - 21
1
2021 - 08 - 02
1
2021 - 06 - 24
1
2021 - 06 - 17
1
2021 - 05 - 25
1
2021 - 04 - 23
1
2021 - 04 - 18
2
2021 - 04 - 16
1
2021 - 04 - 15
2
2021 - 03 - 23
1
2021 - 03 - 12
1
2021 - 03 - 10
1
Sector
Consumer durables
1
Health technology
2
Manufacturing
26
Producer manufacturing
1
Tags
Als
1
Antibody
2
Approval
1
Asco
1
Bexotegrast
2
Biopharma
1
Biotech-bay
1
Cancer
2
Care
1
Clinical trials
7
Clinical-trials-phase-i
1
Clinical-trials-phase-ii
3
Covid
1
Covid-19
1
Designation
1
Drug
4
Enroll
1
Fda
1
Fibrosis
2
Flowmaker
1
Genetown
1
Glaucoma
1
Heart
1
Immunotherapy
1
Life science
1
Liver
3
Management
1
Market
1
N/a
18
Neurological
1
Partnership
2
People
2
Phase 1
1
Phase 2
2
Phase 3
1
Positive
2
Research
3
Sales
3
Stroke
1
T-cell
1
Technology
1
Therapeutics
2
Therapy
2
Treatment
1
Trial
21
Trials
3
Vaccine
1
Entities
4d molecular therapeutics inc
24
Abb ltd
72
Abbvie inc.
62
Actinium pharmaceuticals, inc.
28
Aldeyra therapeutics, inc.
38
Alnylam pharmaceuticals, inc.
38
Alterity therapeutics limited
26
Altra industrial motion corp.
23
Amgen inc.
25
Anavex life sciences corp.
24
Arcutis biotherapeutics, inc.
29
Arrival
26
Arrowhead pharmaceuticals, inc.
23
Astellas pharma inc
26
Astrazeneca plc
64
Beigene, ltd.
35
Biogen inc.
23
Biovie inc.
28
Bioxcel therapeutics, inc.
26
Bristol-myers squibb company
73
Clearside biomedical, inc.
24
Clene inc
25
Cnh industrial n.v.
69
Cybin inc
26
Cytokinetics, incorporated
29
Dynavax technologies corporation
28
Eli lilly and company
161
Enlivex therapeutics ltd.
25
Exelixis, inc.
28
Fortress biotech, inc.
41
Gates industrial corporation plc
25
Gilead sciences, inc.
48
Global industrial co
38
Honeywell international inc.
53
Horizon therapeutics public limited company
46
I-mab
34
Icon plc
43
Immix biopharma, inc.
26
Immutep limited
34
Incyte corporation
49
Johnson & johnson
203
Medtronic plc
25
Merck & company, inc.
72
Moleculin biotech, inc.
34
Novartis ag
34
Novo nordisk a/s
41
Ocugen, inc.
27
Orange
91
Pds biotechnology corporation
24
Pfizer, inc.
61
Plus therapeutics, inc.
35
Regeneron pharmaceuticals, inc.
44
Regenxbio inc.
29
Sanofi
310
Sellas life sciences group, inc.
24
Sorrento therapeutics, inc.
38
Stag industrial, inc.
32
Takeda pharmaceutical company limited
56
Tg therapeutics, inc.
27
Thermo fisher scientific inc
48
Symbols
ARVL
26
CNHI
1
NKLA
1
PLRX
2
Exchanges
Nasdaq
26
Nyse
1
Crawled Date
2024 - 04 - 09
1
2024 - 02 - 05
1
2023 - 10 - 11
1
2023 - 09 - 26
1
2022 - 10 - 13
1
2022 - 06 - 17
1
2022 - 05 - 31
1
2022 - 03 - 21
1
2022 - 03 - 09
1
2022 - 02 - 16
1
2021 - 12 - 28
1
2021 - 09 - 28
1
2021 - 09 - 21
1
2021 - 08 - 02
1
2021 - 06 - 24
1
2021 - 06 - 17
1
2021 - 05 - 25
1
2021 - 04 - 23
1
2021 - 04 - 18
2
2021 - 04 - 16
1
2021 - 04 - 15
2
2021 - 03 - 23
1
2021 - 03 - 12
1
2021 - 03 - 10
1
Crawled Time
00:00
1
06:00
1
06:03
1
08:00
1
09:00
1
10:00
1
11:00
2
12:00
2
12:15
1
13:00
1
13:58
1
14:00
2
14:15
2
15:00
2
16:00
1
16:20
2
17:00
2
20:00
2
Source
www.biospace.com
8
www.globenewswire.com
5
www.prnewswire.com
13
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
trial
entities :
Arrival
save search
DOJ Senior Trial Counsel Amy Kossak Joins Ropes & Gray's Government Enforcement Team
Published:
2024-04-09
(Crawled : 20:00)
- prnewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
Email alert
Add to watchlist
trial
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Published:
2024-02-04
(Crawled : 00:00)
- globenewswire.com
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-28.05%
|
O:
-3.62%
H:
0.0%
C:
-5.78%
liver
positive
fibrosis
bexotegrast
trial
therapeutics
FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial
Published:
2023-10-11
(Crawled : 17:00)
- biospace.com/
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-49.06%
|
O:
6.48%
H:
4.35%
C:
-5.22%
fda
vaccine
care
trial
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Clinical Trial of Bexotegrast in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Published:
2023-09-26
(Crawled : 12:00)
- globenewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-54.35%
|
O:
-1.24%
H:
0.0%
C:
0.0%
PLRX
|
$12.51
2.63%
2.56%
310K
|
Health Technology
|
-14.13%
|
O:
7.89%
H:
11.25%
C:
5.98%
liver
positive
fibrosis
bexotegrast
trial
therapeutics
Treatment of Severe Heart Failure - AI: FineHeart Strengthens Its Management Team in the Run up to the ICOMS FLOWMAKER® First-In-Human Trials
Published:
2022-10-13
(Crawled : 14:00)
- biospace.com/
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-20.55%
|
O:
-0.35%
H:
0.0%
C:
0.0%
flowmaker
treatment
trials
management
heart
Enel X and Arrival Partner to Launch Bus Trials in Italy
Published:
2022-06-17
(Crawled : 09:00)
- globenewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-59.99%
|
O:
-4.0%
H:
0.0%
C:
0.0%
trials
trial
ASCO Preview: Immutep, InxMed and Faron Release New Clinical Findings
Published:
2022-05-31
(Crawled : 14:00)
- biospace.com/
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-69.61%
|
O:
0.0%
H:
0.0%
C:
0.0%
asco
SEC Regional Trial Counsel Amy Jane Longo Joins Ropes & Gray's Litigation & Enforcement Team as Partner in Los Angeles
Published:
2022-03-21
(Crawled : 15:00)
- prnewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-85.25%
|
O:
-2.14%
H:
0.0%
C:
0.0%
trial
COVID-19 Changed the Biopharma Industry - and There's No Going Back
Published:
2022-03-09
(Crawled : 06:00)
- biospace.com/
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-82.48%
|
O:
5.73%
H:
0.0%
C:
0.0%
covid-19
biopharma
covid
Industrial Automation Market size worth $ 350 Billion, Globally, by 2028 at 7.8% CAGR: Verified Market Research®
Published:
2022-02-16
(Crawled : 17:00)
- prnewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-86.25%
|
O:
-1.75%
H:
5.85%
C:
5.09%
research
trial
market
Arrival begins proving ground trials of its electric Bus
Published:
2021-12-28
(Crawled : 10:00)
- globenewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-92.94%
|
O:
0.51%
H:
6.0%
C:
1.79%
als
trials
trial
Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)
Published:
2021-09-28
(Crawled : 14:15)
- biospace.com/
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-95.96%
|
O:
-0.59%
H:
0.3%
C:
-2.44%
stroke
phase 2
neurological
life science
CorWave Attracts Global Talent, Strengthening Its Management Team in Preparation for Clinical Phase and Industrial Ramp Up
Published:
2021-09-21
(Crawled : 08:00)
- biospace.com/
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-95.62%
|
O:
-0.36%
H:
2.24%
C:
0.4%
trial
Global Bispecific Antibody Therapeutics Market Forecast Clinical Trials Drug Approval Insight 2028
Published:
2021-08-02
(Crawled : 15:00)
- prnewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-95.77%
|
O:
0.15%
H:
1.54%
C:
-1.38%
clinical trials
antibody
drug
trial
approval
Medable Launches Digital Certification Program to Accelerate Adoption of Decentralized Clinical Trials
Published:
2021-06-24
(Crawled : 16:00)
- biospace.com/
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-96.68%
|
O:
2.11%
H:
4.43%
C:
1.12%
clinical trials
trial
Behind the Wheel: An electrifying partnership – CNH Industrial and Nikola Corporation
Published:
2021-06-17
(Crawled : 11:00)
- globenewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-97.49%
|
O:
-2.32%
H:
0.89%
C:
-2.7%
CNHI
|
$12.31
-0.73%
0.0%
6.9M
|
Producer Manufacturing
|
-28.35%
|
O:
0.06%
H:
0.41%
C:
-2.44%
NKLA
|
$0.643
-2.58%
-2.64%
52M
|
Consumer Durables
|
-95.94%
|
O:
2.03%
H:
6.78%
C:
5.78%
partnership
trial
Eagle Alpha Announces 3 Key Drivers To Industry Excellence - Trial Dataset Delivery, Data Platform Technology and Stronger Partnerships
Published:
2021-05-25
(Crawled : 12:00)
- prnewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-97.05%
|
O:
0.7%
H:
3.3%
C:
2.83%
partnership
technology
liver
trial
Gamma Delta T Cell Cancer Immunotherapy Clinical Research Trials Pipeline Outlook 2026
Published:
2021-04-23
(Crawled : 14:15)
- prnewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-96.28%
|
O:
3.38%
H:
10.07%
C:
9.93%
immunotherapy
therapy
cancer
research
trial
t-cell
Global C5 Complement Inhibitors Drug Market Sales Clinical Trials Opportunity USD 15 Billion 2026
Published:
2021-04-18
(Crawled : 16:20)
- prnewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
Email alert
Add to watchlist
trial
sales
clinical trials
drug
Global C5 Complement Inhibitor Soliris Ultomiris Market Clinical Trial Research Outlook 2026
Published:
2021-04-18
(Crawled : 16:20)
- prnewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
Email alert
Add to watchlist
trial
research
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.